Serum Bilirubin as a Predictor of Coronary Artery Disease Severity in Patients Undergoing Primary Percutaneous Coronary Intervention

World Journal of Cardiovascular Diseases
doi 10.4236/wjcd.2019.95027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,

Related search

Prognostic Implications of Diastolic Dysfunction Change in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Percutaneous Coronary Intervention for Stable Coronary Artery Disease

Heart
Cardiovascular MedicineCardiology
2018English

Prognostic Significance of Serum Albumin in Patients With Stable Coronary Artery Disease Treated by Percutaneous Coronary Intervention

PLoS ONE
Multidisciplinary
2019English

Effect of Percutaneous Coronary Intervention on Heart Rate Variability in Coronary Artery Disease Patients

European Cardiology Review
Cardiovascular MedicineCardiology
2018English

The Predictive Value of the Syntax Score in Patients With Chronic Coronary Artery Disease Undergoing Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: A Pilot Study

Open Cardiovascular Medicine Journal
Cardiovascular MedicineCardiology
2017English

Relationship Between Serum Procalcitonin Level and Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention

Turkiye Klinikleri Cardiovascular Sciences
Cardiovascular MedicineCardiology
2016English

A Multidirectional Approach to Risk Assessment in Patients With Three-Vessel Coronary Artery Disease Undergoing Percutaneous Intervention

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Mean Platelet Volume in Patients Undergoing Percutaneous Coronary Intervention

Platelets
MedicineHematology
2013English

Percutaneous Coronary Intervention Versus Bypass Grafting in Left Main Coronary Artery Disease

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy